Positioning no disclosures inside 60 days, left as found
Options put/call open interest 9.13, read 2026-10-29
Ethical passes the values gate
Price6.94 USD
Fair value10.83
Ethical score70.0/100
Our investment reviews on this name
2026-10-29Read Markup6.96-0.3% to today Markdown gives way to Markup after an 8% rise in 1 days
2026-10-28Read Markdown6.45+7.6% to today Distribution gives way to Markdown first Markdown read since September
2026-10-18Read Distribution6.53+6.3% to today Markup gives way to Distribution after a 14% slide in 7 days
2026-10-11Read Markup7.62-8.9% to today Distribution gives way to Markup after a 6% rise in 9 days
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
ADTRAN Holdings, Inc. holds its Markup at $6.94. The statistical read favours the buyers, held for 41 days.
As held on the ledger · 2026-10-29
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 41 days
Price at the screen
$6.94
Valuation
N/A trailing · 11.07 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.49
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
20.34%
Below 33%
Interest-bearing debt is just 20.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.08%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
25.44%
Below 49%
Money owed to the company is 25.4% of assets, under the 49% limit.
Pass
Revenue purity
0.21%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
ADTRAN Holdings, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ADTN's ethical verdict changes
Today ADTN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-29 screen. The gold marker is the market price at the same screen. A 56.0% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits +109% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ADTN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Markup · changed$6.96+7.9%Entry 15
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown · changed$6.45+0.0%Entry 14
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$6.45+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$6.45+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$6.45-1.2%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
2026-10-11Markup · changed$7.62+5.7%Entry 9
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
2026-10-02Distribution · changed$7.21+1.7%Entry 8
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
2026-09-19Markdown · changed$7.09-13.1%Entry 7
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 30.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 84%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (6 analysts) rates it buy, with a mean price target of $20.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
